Trial intelligence / Profile preview

Roxadustat for anemia in diabetic nephropathy across CKD stages and effects on renal fibrosis markers

ChiCTR2100044616Phase 4Recruiting

Sponsor
Suqian People's Hospital
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of roxadustat in anaemia and diabetic glomerulosclerosis, sponsored by Suqian People's Hospital. Primary endpoints: hemoglobin, serum ferritin and 3 more. Started Sep 2019; status: recruiting.

02

Drugs

roxadustat
03

Conditions

anaemiadiabetic glomerulosclerosis

Beyond the preview

Go deeper on ChiCTR2100044616.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100044616.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call